Self‐reported quality of life in symptomatic and asymptomatic women with X‐linked adrenoleukodystrophy
Brain and Behavior · 2023
DOI: 10.1002/brb3.2878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2023. Verfasst von Lisa Schäfer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Leukodystrophy Outpatient Clinic, Leipzig University Medical Center, Leipzig, Germany. Hauptthemen laut MEDLINE: Adrenoleukodystrophy, Spinal Cord Diseases, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Leukodystrophy Association (ELA) International.
Abstract (Originalsprache)
Background
Up to 80% of women with X‐linked adrenoleukodystrophy (X‐ALD) develop symptoms of myelopathy and peripheral neuropathy during their lifetime. The study's objective was to compare symptomatic versus asymptomatic women with X‐ALD regarding their physical and mental well‐being and quality of life.
Methods
Data were obtained from a prospective, international, cross‐sectional cohort study of women with X‐ALD recruited both clinically and population based. Symptoms, quality of life, and physical and mental co‐morbidities were assessed by questionnaires. Women were considered symptomatic if they reported any sign of myelopathy or peripheral neuropathy. Group differences between symptomatic versus asymptomatic women and between age groups were examined using χ 2 tests for categorical and independent sample t tests or analysis of variance for continuous variables.
Results
Complete data were available from N = 180 women (mean age: 51.2 ± 13.6 years, range: 18–85), of whom 71.7% were classified as symptomatic, with prevalence increasing with age. Symptomatic versus asymptomatic women reported poorer physical and mental health, with 26.4% meeting the criteria for a clinical depression, 73.6% reporting chronic pain, 80.6% sleeping disturbances, 38.2% sexual dysfunction, and 47.3% restless legs syndrome. Large group differences were found on the physical health, but not on the mental health component of quality of life, where symptomatic women only differed when controlling for having a boy affected by X‐ALD (small effect) and treatment frequency (medium effect).
Conclusions
Symptomatic women with X‐ALD present with physical and psychological co‐morbidities significantly reducing individuals’ quality of life. The findings emphasize the need to develop new multi‐disciplinary treatment options tailored to women's specific needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Leukodystrophy Outpatient Clinic, Leipzig University Medical Center, Leipzig, Germany.
ORCID-Profile: Lisa Schäfer
Förderung
- European Leukodystrophy Association (ELA) International
Zitieren
APA
Schäfer, L., Roicke, H., Bergner, C. C., & Köhler, W. (2023). Self‐reported quality of life in symptomatic and asymptomatic women with X‐linked adrenoleukodystrophy. Brain and Behavior. https://doi.org/10.1002/brb3.2878
Vancouver
Schäfer L, Roicke H, Bergner CC, Köhler W. Self‐reported quality of life in symptomatic and asymptomatic women with X‐linked adrenoleukodystrophy. Brain and Behavior. 2023. doi:10.1002/brb3.2878
BibTeX
@article{Schfer2023,
author = {Schäfer, Lisa and Roicke, Hannes and Bergner, Christa-Caroline and Köhler, Wolfgang},
title = {Self‐reported quality of life in symptomatic and asymptomatic women with X‐linked adrenoleukodystrophy},
journal = {Brain and Behavior},
year = {2023},
doi = {10.1002/brb3.2878}
}
EUVIMED